Gut Health Research Abstract – DR.VEGAN

Gut Health Research Abstract

The Burden, Breadth, and Psychosocial Impact of Gut Health Symptoms: Findings from a Cross-Sectional Survey of 811 Adults

October 2022

Key Findings

  1. 92.0% of respondents reported some degree of gut health issues; mean symptom burden was 6.2 symptoms per respondent, with 41.1% experiencing seven or more simultaneously.
  2. Bloating was the most prevalent symptom (81.0%), followed by fatigue (61.7%), excessive wind or gas (51.9%), and difficulty sleeping (51.2%).
  3. 97.2% of respondents reported that gut health directly affected at least one other dimension of wellbeing - most commonly energy (78.9%), weight (69.7%), and mood (63.5%).
  4. 67.0% reported that gut symptoms worsened when anxious, confirming a strong gut-brain axis relationship in this population.
  5. 83.1% reported at least one psychosocial consequence of their gut symptoms, including social withdrawal (39.2%), mild depression (30.5%), and reduced work capacity (20.2%).
  6. No treatment strategy achieved a "very effective" rating from more than one in five users, demonstrating a substantial unmet need for effective interventions.

Background

Gut health conditions are among the most prevalent chronic complaints in the general population, yet they remain under-represented in research relative to their impact on quality of life. Symptoms such as bloating, fatigue, constipation, and low mood are frequently dismissed or inadequately managed, and the psychological impact of living with chronic gastrointestinal symptoms is poorly characterised. This study aimed to describe the prevalence, multi-symptom burden, systemic impact, and psychosocial consequences of gut health issues across a large adult sample and to assess existing treatment strategies and their effectiveness. The survey was conducted by DR.VEGAN®, October 2022.

Methods

A cross-sectional online survey was administered to 811 adults. Individual-level response data were available for all analyses. The survey captured gender, dietary profile, self-rated severity of gut health issues, regularly experienced symptoms, the perceived systemic impact of gut health on multiple dimensions of wellbeing, the relationship between anxiety and gut symptoms, psychological and social consequences, motivations for improving gut health, food intolerances, dietary triggers, IBS status, treatments tried and their effectiveness, and engagement with healthcare professionals.

Results

Sample characteristics

Of 811 respondents, 86.7% (n=703) were female and 13.1% (n=106) male. The mean age was 54.2 years (median 54, range 19–100), with the majority aged 45–54 (37.7%) or 55 and over (46.8%). Diet was predominantly omnivorous (54.1%), with 12.1% flexitarian, 12.1% vegan, 9.4% vegetarian, and 5.8% pescatarian. Most respondents reported meaningful gut health difficulties: 10.9% described extreme or severe gut health issues, 46.1% regular issues, and 35.0% occasional issues. Only 8.0% reported no gut health issues at all.

Symptom prevalence and burden

Of 715 respondents, bloating was by far the most prevalent complaint (81.0%, n=579). The symptom burden was substantial: the mean number of symptoms per respondent was 6.2 (median 6), with 41.1% reporting seven or more distinct symptoms simultaneously. See Figure 1 for the full symptom prevalence profile.

Figure 1. Symptom prevalence across all respondents (n=715)
Symptom Prevalence (n=715) n
Bloating 81.0% 579
Fatigue 61.7% 441
Excessive wind or gas 51.9% 371
Difficulty sleeping / insomnia 51.2% 366
Weight gain 47.7% 341
Constipation 44.2% 316
Low moods and anxiety 43.2% 309
Muscle aches 39.9% 285
Diarrhoea 32.7% 234
Skin health issues 32.7% 233
Acid reflux 32.4% 232
Urgency to use the toilet 28.4% 203
Stomach cramps 27.1% 194
Heartburn 19.2% 137
Heart palpitations 17.5% 125
Nausea 14.1% 101
Pelvic pain 13.3% 95
% = proportion of 715 respondents who answered the symptoms question. Multiple responses permitted. Rows ordered by prevalence.

Systemic impact of gut health

Of 712 respondents, 97.2% reported that gut health had a direct impact on at least one other dimension of their wellbeing. See Figure 2 for the full systemic impact profile.

Figure 2. Systemic impact of gut health on dimensions of wellbeing (n=712)
Dimension of wellbeing affected % reporting impact n (of 712)
Energy 78.9% 562
Weight 69.7% 496
Mood 63.5% 452
Stress and anxiety 56.3% 401
Sleep 50.6% 360
Focus and concentration 37.4% 266
Skin health 32.7% 233
Sex drive 24.9% 177
Hair 23.3% 166
% = proportion of 712 respondents who answered this question. Multiple responses permitted. Rows ordered by frequency.

The gut-anxiety relationship

Of 715 respondents, 67.0% (n=479) reported that their gut health symptoms became worse when they were anxious, with only 12.0% reporting no such relationship and 21.0% being unsure. This strong bidirectional association between gut symptoms and anxiety, consistent with the established gut-brain axis, highlights that effective gut health management cannot be separated from psychological wellbeing.

Psychosocial consequences

Gut health symptoms generated substantial psychosocial burden. Of 712 respondents, 83.1% reported at least one psychosocial consequence. See Figure 3 for the full psychosocial consequence profile.

Figure 3. Psychosocial consequences of gut health symptoms (n=712)
Psychosocial consequence % reporting (n=712) n
Feeling fed up 58.3% 415
Symptoms restricting daily life 46.2% 329
Avoiding social contact / not wanting to go out 39.2% 279
Mild depression 30.5% 217
Not wanting to work 20.2% 144
Feeling incapable 12.5% 89
Severe depression 6.3% 45
% = proportion of 712 respondents who answered this question. Multiple responses permitted. Rows ordered by frequency.

Food intolerances and dietary triggers

Of 685 respondents, 45.3% identified at least one food intolerance, with dairy (21.3%), wheat (17.4%), gluten (16.4%), and lactose (12.3%) most commonly reported. Of 687 respondents, 91.6% identified at least one dietary trigger, with refined bread (55.6%), alcohol (35.2%), and milk and dairy (32.2%) most frequently cited.

IBS status

Of 690 respondents, 25.9% (n=179) had a formal IBS diagnosis and 17.4% (n=120) were confident they had IBS without a formal diagnosis – giving a combined probable IBS prevalence of 43.3%. A further 24.3% were unsure, and only 30.3% were confident they did not have IBS.

Treatment strategies and effectiveness

Of 690 respondents, 93.0% had tried at least one strategy to address their gut symptoms. See Figure 4 for strategies tried and effectiveness ratings.

Figure 4. Treatment strategies tried and self-rated effectiveness (n=690)% very / somewhat effective = combined positive rating among those who tried each strategy.
Treatment strategy % tried % very / somewhat effective
Avoiding specific foods or drinks 67.1% 87.7%
Probiotic supplements 65.9% 80.3%
Elimination diet 34.9% 84.2%
Medication 31.3% 79.3%
Digestive enzyme supplements 26.4% 75.7%
% tried = proportion of 690 respondents who had tried each strategy. % very / somewhat effective = combined positive effectiveness rating among those who had tried each strategy.

Healthcare engagement and motivations

Of 682 respondents, 63.5% had seen a healthcare professional about their gut symptoms, most commonly a GP (56.7%). Service quality was rated as only excellent or good by 49.1% of those who had seen someone, with 35.9% rating it average and 15.1% poor or very poor. The leading motivations for investing in gut health were reducing bloating (77.3%), having more energy (67.3%), losing weight (51.4%), improving body confidence (46.4%), and improving sleep (44.5%).

Conclusions

This large survey of 811 adults demonstrates that gut health symptoms impose a high, multi-symptom burden (mean 6.2 symptoms per respondent); affect nearly every dimension of wellbeing, including energy, mood, sleep, and concentration; and generate substantial psychosocial consequences, including social withdrawal, depression, and reduced work capacity. The strong relationship between anxiety and gut symptoms (67.0%) confirms the clinical relevance of the gut-brain axis for this population. Existing management strategies provide only partial relief, with no treatment achieving very effective ratings in more than one in five users. These findings demonstrate a significant unmet need for effective, accessible, non-pharmacological interventions for gut health.

Keywords: gut health, IBS, bloating, fatigue, gut-brain axis, anxiety, psychosocial impact, probiotic supplements, food intolerances, women’s health

Survey date: 2022   |  Sample size: N = 811   |  Data: Individual-level responses   


Media enquiries: Please contact [email protected]

 

Basket

Your shopping basket is empty. Need some help?
Our Virtual Nutritionist is here to assist you.

Try now

Add to your stack

Gut Works®

Gut Works®

(410)
£32.99

Vegan Omega 3

Vegan Omega 3

(72)
£21.99

Magnesium Glycinate

Subtotal

£0.00

Shipping and taxes calculated at checkout.